MedTrace Logo

The Bacterial Secretome in IBD

NCT04136587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2025-03-26

No results posted yet for this study

Summary

Secreted bacterial effectors produced by the intestinal microbiota are in part responsible for the proinflammatory effect of the fecal content in inflammatory bowel disease (IBD) patients.

Conditions

  • Inflammatory Bowel Diseases

Interventions

OTHER

Colonic fluid collection during endoscopy for analysis of the bacterial secretome

Colonic content will be collected by suction during routine colonoscopy including the residual fluid in the colon and stool contents and also suction of washing fluid (sterile physiologic H2O solution)

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Christoph Hoegenauer, Prof · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04136587 on ClinicalTrials.gov